NuPathe Reports Positive Phase I Results For NP101, A Novel Transdermal Patch For Acute Migraine
NuPathe Reports Positive Phase I Results For NP101, A Novel Transdermal Patch For Acute Migraine |
|
May Tenormin help us?uses of Tenormin Tenormin is a beta-blocker used to treat chest pain ( angina ) and high blood pressure. It is also used after an acute heart attack to improve survival. High blood pressure reduction helps prevent strokes, heart attacks and kidney problems. how to use of Tenormin Take Tenormin by mouth, usually once daily; or as directed by your doctor. Use Tenormin regularly in order to get most benefit from it. To help we remember, use it at same time each day. other used of Tenormin This section contains uses of Tenormin that aren't listed in approved professional labeling for the drug but that may be prescribed by your health care professional. Use Tenormin for a condition that is listed in this section only if it has been so prescribed by your health care professional. side effects of Tenormin We may experience dizziness, lightheadedness, drowsiness, tiredness, nausea, diarrhea, unusual dreams, leg pain, or vision problems as your body adjusts to medication. If any of these effects persist or worsen, notify your doctor or pharmacist promptly. precautions of Tenormin Before taking Tenormin, tell your doctor or pharmacist if you're allergic to it; or to other beta-blockers ( e. g. , metoprolol, propranolol ) ; or if we have any other allergies. interactions of Tenormin Your doctor or pharmacist may already be aware of any possible drug interactions and may be monitoring we for it. Don't start, stop or change dosage of any medicine before checking with them first. overdose of Tenormin If overdose of Tenormin is suspected, contact your local poison control center or emergency room immediately. US residents can call US national poison hotline at 1-800-222-1222. Canadian residents should call their local poison control center directly. Symptoms of overdose may include unusually slow heartbeat, severe dizziness, slow or shallow breathing, weakness, or fainting. notes of Tenormin Don't share Tenormin with others. Lifestyle changes such as stress reduction programs, exercise and dietary changes may increase the effectiveness of this medicine. Talk to your doctor or pharmacist about lifestyle changes that might benefit you. missed dose of Tenormin If we miss a dose Tenormin, take it as soon as you remember, but not if it is within 8 hours of next dose. If it's within 8 hours of the next dose, skip missed dose and resume your usual dosing schedule. Don't double dose to catch up. storage of Tenormin Store Tenormin at room temperature between 68 and 77 degrees F ( between 20 and 25 degrees C ) away from light and moisture. Don't store Tenormin in bathroom. Keep all medicines away from children and pets. warning of Tenormin If we have chest pain ( angina ) or have heart disease ( e. g. , coronary artery disease, ischemic heart disease, high blood pressure ) , do not stop using Tenormin without first consulting your doctor. Your condition may become worse when drug is suddenly stopped. If your doctor decides you should no longer use Tenormin, you must gradually decrease your dose according to your doctor's instructions. Where to buy cheap Tenormin |
NuPathe Reports Positive Phase I Results For NP101, A Novel Transdermal Patch For Acute Migraine NuPathe Inc. , a privately held specialty pharmaceutical company developing innovative products for the treatment of neurological and psychiatric diseases, announced positive Phase I results for NP101, a novel drug-device patch for acute migraine in clinical development. NP101 combines NuPathe's SmartRelief™ proprietary iontophoretic transdermal technology with sumatriptan, most widely prescribed treatment for acute migraine in United States and active ingredient in Imitrex�. The study was a Phase I, single center, single-dose, open label, five-way crossover study to compare pharmacokinetics of two NP101 patch formulations with three FDA approved formulations of Imitrex� ( 20 mg nasal spray, 100 mg oral tablet, 6 mg subcutaneous injection ) in 23 healthy volunteers. Tolerability and safety were assessed for all formulations and skin evaluations were performed for subjects after administration of NP101. Results of the study were presented June 28, 2008 at American Headache Society meeting in Boston, MA. The plasma concentrations for NP101 were more consistent among subjects compared to either 20 mg nasal spray or 100 mg oral tablet formulations. " These findings support the hypothesis that parenteral administration of sumatriptan, either through subcutaneous injection or transdermal delivery, provides a more predictable method of drug delivery by bypassing absorption through gastrointestinal system, " said Mark Pierce, M. D. , Ph. D. , chief scientific officer at NuPathe who presented the results in Boston. NP101 was well tolerated. Adverse events for NP101 were generally mild and most resolved without treatment. The most common reported adverse event was pruritus at patch application site. Upon patch removal, 75% of subjects had minimal or no skin erythema and by 48 hours all subjects had minimal or no erythema. No subject withdrew from study due to skin irritation. No subject reported atypical sensations such as flushing or pain and pressure sensations after application of NP101. These adverse events, common with triptans, were reported for both 6 mg subcutaneous injection and the 100 mg oral tablet at frequencies similar to previously reported data. " This absence of atypical, pain and pressure sensations with NP101 patch may reflect lower and more consistent peak plasma concentration levels obtained with NP101 patches when compared to 100 mg oral tablet and 6 mg subcutaneous injection of Imitrex�, " reported Dr. Pierce. According to Jane Hollingsworth, chief executive officer of NuPathe, " Patients clearly need better options for acute migraine. Triptans, gold standard in treatment today, can be quite efficacious, but are inadequate for many in their current forms. Many patients experience difficulty taking their medication due to nausea that accompanies their migraine and many experience troublesome side effects from current medications. " Ms. Hollingsworth also said that " The results of this study are extremely exciting for patients and NuPathe as they demonstrate that NP101 delivers sumatriptan in a rapid, predictable, and consistent manner. Large Phase III clinical trials are being initiated now to evaluate efficacy and safety of NP101 for treatment of acute migraine. " About NuPathe NuPathe Inc. is a specialty pharmaceutical company developing innovative therapeutic products for treatment of neurological and psychiatric diseases. NuPathe's mission is to identify and address needs of patients that are insufficiently met by current treatments. NuPathe's product portfolio includes NP101, which, if approved, will be the first and only transdermal patch for treatment of acute migraine, and NP201, a 2-3 month injectable implant for treatment of Parkinson's disease. About NP101 NP101 is a novel drug-device patch in clinical development for acute migraine. Today, only 50% of migraine patients are satisfied with their migraine treatment due to issues such as migraine-associated nausea/vomiting, inconsistent relief, and side-effects. NP101 was designed to address these issues, providing patients with improved ability to take control over their migraine as compared to currently available oral and non-oral options. NP101 is based on NuPathe's proprietary SmartRelief™ technology, a breakthrough in iontophoretic patch technology that utilizes low-level electrical energy to transport drugs through skin. Imitrex� is a registered trademark of GlaxoSmithKline. NuPathe Inc. The advises from medical professionals |
Warning on Certain Types of Raw Red Tomatoes. FDA is alerting consumers in New Mexico and Texas that a salmonellosis outbreak appears to be linked to consumption of certain types of raw red tomatoes and products containing raw red tomatoes. Recent Generic Drug Approvals. Each year, FDA approves scores of new generic drugs that help consumers save money. Here are some of the most significant generic approvals of the past year. Warning About Total Body Liquid Supplements. FDA is advising consumers not to buy or use certain Total Body liquid dietary supplement products because of reports of serious reactions. Second Safety Warning on Fentanyl Skin Patch. FDA issued its second safety warning about the fentanyl skin patch because the agency has continued to receive reports of death and life-threatening side effects. FDA Safety Update: Asthma Medications. May is Asthma and Allergy Awareness Month. Here is a roundup of recent safety issues related to asthma medications. Red Tomato Warning Expanded Nationwide. The Food and Drug Administration is expanding its warning to consumers nationwide that a salmonellosis outbreak has been linked to consumption of certain raw red plum, red Roma, and red round tomatoes, and products containing these tomatoes. |
Beware of Online Cancer Fraud. FDA and the Federal Trade Commission have launched a program targeting online health fraud that takes advantage of people with cancer. Protect yourself with this advice. Making Sense of Vytorin Concerns. This article clarifies the results of a study that was published in the New England Journal of Medicine, and emphasizes the importance of continuing on prescribed cholesterol medications. Living with Fibromyalgia, Drugs Approved to Manage Pain. A second drug has been approved to treat fibromyalgia, a painful chronic condition that affects the muscles and joints. Red Tomato Warning Expanded Nationwide. The Food and Drug Administration is expanding its warning to consumers nationwide that a salmonellosis outbreak has been linked to consumption of certain raw red plum, red Roma, and red round tomatoes, and products containing these tomatoes. FDA 101: How to Use the Consumer Complaint System and MedWatch. When you have a problem with a food, drug, or other FDA-regulated product, FDA wants to hear from you. Here's how to report problems using two of FDA's main reporting systems. Your Guide to Reporting Problems to FDA. This guide provides tips and a quick-reference chart to help you report a problem to FDA. Warning for Regranex�"Cream for Leg and Foot Ulcers. A boxed warning has been added to the label of Regranex Gel 0.01% to address the increased risk of cancer death in patients who use three or more tubes of the product. |
|
NuPathe Reports Positive Phase I Results For NP101, A Novel Transdermal Patch For Acute Migraine May Tenormin help us? Where to buy cheap Tenormin Warning on Certain Types of Raw Red Tomatoes. FDA is alerting consumers in New Mexico and Texas that a salmonellosis outbreak appears to be linked to consumption of certain types of raw red tomatoes and products containing raw red tomatoes. The advises from medical professionals |
